BNGO CIK: 1411690

Bionano Genomics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
272
FY22:
157
FY23:
140
FY24:
39.5
FY25:
45.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
105
FY22:
150
FY23:
74.3
FY24:
37.2
FY25:
28.2
Total assets
Change from FY21 to FY25
millions USD
FY21:
377
FY22:
308
FY23:
214
FY24:
76.7
FY25:
73.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
21.8
FY22:
35.9
FY23:
100
FY24:
37.3
FY25:
22.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
18.1
FY22:
22.2
FY23:
18.2
FY24:
3.95
FY25:
6.22
(positive)
Change from FY21 to FY25
millions USD
FY21:
337
FY22:
249
FY23:
96.2
FY24:
35.4
FY25:
44.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
377
FY22:
308
FY23:
214
FY24:
76.7
FY25:
73.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data